- Home | Harrow, Inc.
Harrow is redefining the standard of care in eyecare with a portfolio of trusted, high-value pharmaceutical solutions that deliver proven safety, efficacy, and affordability
- Harrow Announces First-Quarter 2025 Financial Results
Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
- Corporate Presentation November 2025 - harrow. com
Harrow was founded to advance the standard of eye care and deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes
- SEC Filings | Harrow, Inc.
The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
- Harrow Announces Agenda and Speakers for Investor Analyst Day
Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes
- Careers | Harrow, Inc.
At Harrow, we’re always interested in connecting with talented, purpose-driven, and mission-minded individuals who share our passion for advancing eye health and improving patients’ lives
- 0001493152-25-012840 | 8-K | iXBRL Viewer | Harrow INC
Harrow INC SEC filing: Form 8-K iXBRL on 09 09 2025 (0001493152-25-012840)
- Quarterly Results | Harrow, Inc.
The Investor Relations website contains information about Harrow, Inc 's business for stockholders, potential investors, and financial analysts
|